Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
filingDate |
2019-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2021-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-102267378-B1 |
titleOfInvention |
Pharmaceutical composition for treating and preventing breast cancer comprising C12, C16 or C18-ceramide as an active ingredient |
abstract |
The present invention relates to a pharmaceutical composition for preventing or treating breast cancer containing C12, C16 or C18-ceramide as an active ingredient, C12, C16 or C18-ceramide increases estrogen receptor degradation, and fulvestrant When treated with fulvestrant, it increases the estrogen receptor degradation effect and apoptosis effect by fulvestrant, so it can be usefully used for prevention and treatment of breast cancer. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102544632-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102569192-B1 |
priorityDate |
2019-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |